253 |
Trends in Surgical and Transcatheter AVR: Asan Medical Center Experience |
Joon Bum Kim |
Aug. 07. 18 |
252 |
Impact of Paravalvular Regurgitation After TAVR on LV Geometry |
Euihong Ko |
Aug. 07. 18 |
251 |
Impact of Renal Function on Stroke or Systemic Embolism Following TAVR |
Jung-Min Ahn |
Aug. 07. 18 |
250 |
Clinical Impact of Periprocedural Myocardial Injury After TAVR |
Duk-Woo Park |
Aug. 07. 18 |
249 |
J-Valve: Development, Design, and Data |
Jian (James) Ye |
Aug. 07. 18 |
248 |
TAVR for Pure AR: International Registry Data and Technical Pearls |
Anna Sonia Petronio |
Aug. 07. 18 |
247 |
TAVR in Asia, Korea, and AMC |
Seung-Jung Park |
Aug. 07. 18 |
246 |
Next Generation TAVR Devices |
Eberhard Grube |
Aug. 07. 18 |
245 |
TAVR Outcome of Venus and Venibri Valves |
Horst Sievert |
Aug. 07. 18 |
244 |
When LOW Is TOO LOW |
Owen Christopher Raffel |
Aug. 07. 18 |